Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition
Clinical trial NCT04542291 · COMPLETED
Trial details
- NCT number
- NCT04542291
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-12-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.